Eraxis (anidulafungin) for serious Candida fungal infections

June 2006

Pfizer will be promoting Eraxis (anidulafungin) for serious Candida fungal infections.

It's similar to Cancidas (caspofungin) and Mycamine (micafungin). These "candins" inhibit formation of the fungal cell wall.

Eraxis is given IV. It will be used for Candida infections in the bloodstream. It's more effective than fluconazole.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

New guidelines shed light on preventing heart attacks and strokes in patients who already have cardiovascular disease
Women's Health Enjuvia is a new synthetic conjugated estrogens tablet
Respiratory & Allergy vigorously shake Combivent inhalers for 10 seconds before EVERY puff
Vaccines mumps in and around Iowa is the largest outbreak in 20 years
Antidepressants how to switch antidepressants
new methylphenidate PATCH called Daytrana
Vivitrol is a new injectable naltrexone for alcohol dependence
Chantix (varenicline) for smoking cessation
Pediatrics Vusion, a new Rx ointment for diaper rash
Infectious Diseases quinolones being overused for uncomplicated urinary tract infections (UTIs)
Infectious Diseases People will soon be asking what to use for "swimmer's ear"
Infectious Diseases Eraxis (anidulafungin) for serious Candida fungal infections
Thyroid Disorders levothyroxine absorption may depend on gastric acidity
Gastroenterology Oral sodium phosphate bowel preps may harm the kidneys in some patients
Medicare D patients won't lose coverage for a specific drug even if their plan's formulary changes